Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
FreeStride Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
FreeStride Therapeutics

FreeStride Therapeutics

FreeStride Therapeutics develops innovative therapies for companion animals, targeting arthritis and lameness for enhanced healing.

HQ
Ann Arbor, MI, US
Founded
2009
Overview
Compare
Fundraising
Employees

FreeStride Therapeutics, Inc. was created for one purpose: to develop a companion animal therapy that goes beyond medicating the pain of arthritis and lameness by targeting the mechanisms that result in healing.

They are dedicated to creating a safe, effective treatment that will restore horses, dogs and cats to active lifestyles so they can enjoy their lives with you. Their management team draws upon decades of experience in biotechnology, research, the business of Life Science, and drug development.

FreeStride Therapeutics - Similar Companies

StrideBio logo

StrideBio

stridebio.com

Hilltop Biosciences logo

Hilltop Biosciences

hilltopbio.com

Companion Pharma logo

Companion Pharma

Aniluxx Biotechnology logo

Aniluxx Biotechnology

aniluxx.com

Animal Cell Therapies logo

Animal Cell Therapies

MBF Therapeutics logo

MBF Therapeutics

Stride Therapy logo

Stride Therapy

stridethera.com

mystride logo

mystride

Animal Biosciences logo

Animal Biosciences

Traverse Biosciences logo

Traverse Biosciences

AnimalBiome logo

AnimalBiome

animalbiome.com

PetVivo Holdings logo

PetVivo Holdings

petvivo.com

Strykagen logo

Strykagen

Curelab Veterinary logo

Curelab Veterinary

VetDC logo

VetDC

FreeStride Therapeutics - Quick Facts

Who are FreeStride Therapeutics' competitors?

Companies similar to FreeStride Therapeutics include StrideBio, Hilltop Biosciences, Companion Pharma and Aniluxx Biotechnology.

When was FreeStride Therapeutics founded?

FreeStride Therapeutics was founded in 2009.

Where is FreeStride Therapeutics' headquarters located?

FreeStride Therapeutics' headquarters is located in Ann Arbor, MI, US.

When was FreeStride Therapeutics' last funding round?

FreeStride Therapeutics' most recent funding round was for $100k (USD) in July 2012.

How much has FreeStride Therapeutics raised to-date?

As of Jul 13, 2012, FreeStride Therapeutics has raised a total of $100k (USD).

How many employees does FreeStride Therapeutics have?

FreeStride Therapeutics has 5 employees as of Feb 4, 2024.

FreeStride Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Animal Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified